Mesothelioma Chemotherapy Drugs
Alimta
Manufactured by Eli Lilly and Company Pharmaceuticals, Alimta is a breakthrough drug for those with mesothelioma...
Carboplatin
Most commonly used for the treatment of ovarian and lung cancer, Bristol Myers Squibb’s carboplatin has also been used to treat sufferers of pleural malignant mesothelioma...
Cisplatin
A member of the family of chemotherapy drugs known as platinum containing compounds or alkylating agents...
Gemcitabine
Part of the group of drugs known as anti-metabolites, Gemcitabine is used in the treatment of malignant mesothelioma as well as lung, bladder, breast, and pancreatic cancer...
Navelbine
Navelbine® is a chemotherapy drug that has been traditionally used for a number of different kinds of cancer, including breast cancer and non-small-cell lung cancer...
Onconase
Currently in clinical trials, Onconase, manufactured by Alfacell Corporation, offers hope to patients with unresectable malignant mesothelioma...
Thank you for visiting this website which is created for the benefit of the general public. This website and its content are produced and sponsored by the law firm of James F. Early, LLC (James F. Early, Esq.). This website is devoted to the needs of people diagnosed with mesothelioma; nonetheless it may be considered attorney advertising. The content contained herein was not prepared by medical professionals and it is not intended, nor should it be considered, as a substitute for medical advice. The information provided on this website is intended as educational material, designed solely to support, and not replace, the relationship that exists between a patient/site visitor and his/her healthcare professional. Additionally, neither visiting this website nor viewing its content is intended, and shall not be considered, to create an attorney-client relationship. An attorney-client relationship can only be created by mutual agreement and consent of the prospective client and the attorney. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may not apply to your particular factual or legal circumstances. Online readers should not act on this information without seeking professional counsel and advice.
Please read our disclaimer for more information.